HIF dysregulation as a novel genetic model to study retinal neovascular disease.
HIF dysregulation as a novel genetic model to study retinal neovascular disease.
批准号:
8032771
负责人:
Akrit Singh Sodhi
金额:
$17.96万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-04-01 至 2016-03-31
关键词:
AddressAge related macular degenerationAreaBiochemicalBlindnessBlood VesselsBlood-Retinal BarrierCell CommunicationCellsClinicalConfocal MicroscopyDevelopmentDiseaseEdemaEtiologyEventEyeEye NeoplasmsFamilyFluorescence Resonance Energy TransferGenesGenetic ModelsGoalsGrowthGrowth FactorHistopathologyHumanHypoxiaHypoxia Inducible FactorImaging TechniquesIschemiaLesionLifeMacular degenerationMentorsModelingMolecularMusNeovascular GlaucomaPathogenesisPathologic NeovascularizationPatientsPhenotypePrincipal InvestigatorProductionProteinsRegulationRelative (related person)ResearchResearch PersonnelRetinaRetinalRetinal Artery OcclusionRetinal DiseasesRetinal NeovascularizationRetinopathy of PrematurityRoleStimulusStructure of central vein of the retinaSyndromeTestingTissuesTrainingTumor Suppressor GenesUp-RegulationVHL proteinVascular Endothelial Growth FactorsVascular PermeabilitiesVon Hippel-Lindau SyndromeWorkangiogenesisbaseexperiencehemangioblastomahypoxia inducible factor 1in vivoin vivo Modelinsightinterestneovascularneovascularizationnoveloverexpressionprogramsproliferative diabetic retinopathyprotein complexskillstranscription factortumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The overall goal of this proposal is to provide the principal investigator (PI) with the experience and skills necessary to become an independent researcher studying basic mechanisms of retinal neovascular disease. The scientific focus of this proposal is to gain a better understanding of pathological angiogenesis in the eye, a principal cause of irreversible blindness worldwide. Emerging evidence suggests a shared etiology for neovascularization in the eye in which local hypoxia leads to upregulation of the hypoxia inducible factor (HIFs). HIFs are a family of transcription factors which stimulate production of several "hypoxia inducible" genes, including angiogenic growth factors (e.g. vascular endothelial growth factor or VEGF), which, in turn, promote the growth of (leaky) blood vessels. Of interest, significant progress in our understanding of the regulation of HIFs in pathological angiogenesis has come from recent work examining the dysregulation of HIFs in patients with von Hippel-Lindau (VHL) disease. Retinal hemangioblastomas are neovascular tumors that remain the most common clinical manifestation in patients with VHL disease, often manifesting with profuse edema and resulting in profound loss of vision. The VHL protein (pVHL) targets HIFs for degradation. Therefore, loss of pVHL in patients with VHL disease results in dysregulation of HIFs and over expression of hypoxia-inducible genes, mimicking pathological angiogenesis. The underlying hypothesis of this proposal is that VHL retinal hemangioblastomas are a model for pathological angiogenesis and provide an ideal genetic model to examine the role(s) of HIFs and their targets in the breakdown of the inner blood- retinal barrier (iBRB), a poorly understood, but critical early event in retinal neovascular disease. To address this hypothesis, three specific aims are proposed: Aim 1: To examine the necessity for HIFs in the breakdown of the iBRB. Aim 2: To determine if HIF dysregulation is sufficient to promote breakdown of the iBRB. Aim 3: To determine the relative contribution of HIF-dependent growth factors in breakdown of the iBRB. In the course of the proposed research and selected didactic activities, the PI will gain invaluable training experience and mentoring in studying the molecular pathogenesis of retinal neovascular disease. This expertise is deemed essential for the PI who aspires to develop an independent research program studying basic mechanisms of retinal pathological angiogenesis.
PUBLIC HEALTH RELEVANCE: Retinal neovascular disease is the leading cause of irreversible blindness in the developed world. This proposal intends to study the underlying cellular and biochemical changes leading to the breakdown of the inner blood-retinal barrier by studying a novel genetic model for retinal neovascular disease. In addition to numerous retinal diseases (e.g. proliferative diabetic retinopathy, ischemic vascular occlusions, retinopathy of prematurity, and macular degeneration), these studies may promote a greater appreciation for the cause of other ocular diseases which involve dysregulated angiogenesis (e.g. ocular tumors and neovascular glaucoma).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular Engineering of Novel Therapies to Treat Corneal Neovascularization
-
批准号:10592879
-
项目类别:
-
资助金额:$24.56万
-
财政年份:2023
-
负责人:Akrit Singh Sodhi
-
依托单位:
Divergent Roles for Hypoxia-Inducible Factor-1 and -2 in Ischemic Retinal Disease
-
批准号:10589944
-
项目类别:
-
资助金额:$53.03万
-
财政年份:2019
-
负责人:Akrit Singh Sodhi
-
依托单位:
Divergent Roles for Hypoxia-Inducible Factor-1 and -2 in Ischemic Retinal Disease
-
批准号:10359204
-
项目类别:
-
资助金额:$51.44万
-
财政年份:2019
-
负责人:Akrit Singh Sodhi
-
依托单位:
HIF dysregulation as a novel genetic model to study retinal neovascular disease.
-
批准号:8242691
-
项目类别:
-
资助金额:$17.96万
-
财政年份:2011
-
负责人:Akrit Singh Sodhi
-
依托单位:
HIF dysregulation as a novel genetic model to study retinal neovascular disease.
-
批准号:8857468
-
项目类别:
-
资助金额:$17.96万
-
财政年份:2011
-
负责人:Akrit Singh Sodhi
-
依托单位:
HIF dysregulation as a novel genetic model to study retinal neovascular disease.
-
批准号:8650284
-
项目类别:
-
资助金额:$17.96万
-
财政年份:2011
-
负责人:Akrit Singh Sodhi
-
依托单位:
HIF dysregulation as a novel genetic model to study retinal neovascular disease.
-
批准号:8440784
-
项目类别:
-
资助金额:$17.96万
-
财政年份:2011
-
负责人:Akrit Singh Sodhi
-
依托单位:
海外基金